The Mitragyna speciosa (kratom) alkaloid mitragynine: Analysis of adrenergic α2 receptor activity in vitro and in vivo-Reference-Cited by-同舟云学术

The Mitragyna speciosa (kratom) alkaloid mitragynine: Analysis of adrenergic α2 receptor activity in vitro and in vivo

Published:2024-10 Issue: Volume:980 Page:176863
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Obeng Samuel^ORCID,Crowley Morgan L.,Mottinelli Marco,León Francisco^ORCID,Zuarth Gonzalez Julio D.,Chen Yiming,Gamez-Jimenez Lea R.,Restrepo Luis F.,Ho Nicholas P.,Patel Avi^ORCID,Martins Rocha Joelma^ORCID,Alvarez Manuel A.,Thadisetti Amsha M.,Park Chai R.,Pallares Victoria L.C.,Milner Megan J.^ORCID,Canal Clinton E.^ORCID,Hampson Aidan J.^ORCID,McCurdy Christopher R.^ORCID,McMahon Lance R.^ORCID,Wilkerson Jenny L.^ORCID,Hiranita Takato

Funder

Texas Tech University Health Sciences Center

National Institute on Drug Abuse

University of Florida

Publisher

Elsevier BV

Reference53 articles.

1. Self‐treatment of opioid withdrawal using kratom (Mitragynia speciosa korth);Boyer;Addiction,2008

2. Two α2-adrenergic receptor subtypes, α2A and α2C, inhibit transmitter release in the brain of gene-targeted mice;Bücheler;Neuroscience,2002

3. Overdose mortality rates for opioids and stimulant drugs are substantially higher in men than in women: state-level analysis;Butelman;Neuropsychopharmacology,2023

4. Exploring the chemistry of alkaloids from Malaysian Mitragyna speciosa (kratom) and the role of oxindoles on human opioid receptors;Chear;J. Nat. Prod.,2021

5. Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction;Cheng;Biochem. Pharmacol.,1973